text: Future therapies involve use of factor X inhibitors or direct thrombin inhibitors. The data is currently not mature enough to make any clinical recommendations.
option_0: Heparin-induced thrombocytopenia future or investigational therapies
option_1: Glanzmann's thrombasthenia medical therapy
option_2: Glanzmann's thrombasthenia future or investigational therapies
option_3: Heparin-induced thrombocytopenia primary prevention
option_4: Heparin-induced thrombocytopenia medical therapy
option_5: Thrombotic thrombocytopenic purpura medical therapy
option_6: Thrombotic thrombocytopenic purpura secondary prevention
option_7: Antiphospholipid syndrome primary prevention